hPL- and FBS treated mesenchymal stem cell sequencing
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Mesenchymal Stem Cell property changes
应用场景：
创建时间：
2023-04-07
相关数据集
Cell Therapy Processing Market Size to Flourish at a CAGR of 27.60% by 2031
The global cell therapy processing market size was valued at USD 4,493.37 million in 2022. It is estimated to reach USD 40,292.87 million by 2031, growing at a CAGR of 27.60% during the forecast perio
straitsresearch.com2025-03-26 更新100
Baseline parameters.
Objectives Current osteoarthritis treatments are designed to reduce pain and improve mobility instead of promoting the regeneration of cartilage. Cell-based therapies are being developed for the treat
NIAID Data Ecosystem40
Supplementary Material for: Culture of Mouse Amniotic Fluid-Derived Cells on Irradiated STO Feeders Results in the Generation of Primitive Endoderm Cell Lines Capable of Self-Renewal in vitro
The cells present in amniotic fluid (AF) are currently used for prenatal diagnosis of fetal anomalies but are also a potential source of cells for cell therapy. To better characterize putative progeni
DataCite Commons2020-09-02 更新30
Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses
Infusion of human third-party mesenchymal stromal cells (MSCs) appears to be a promising therapy for acute graft-versus-host disease (aGvHD). To date, little is known about how MSCs interact with the
NIAID Data Ecosystem70
Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells.
To realize the full potential of human embryonic stem cells (hESC), it is important to develop culture conditions that maintain hESC in a pluripotent, undifferentiated state. A low O2 atmosphere (~4%
NIAID Data Ecosystem40
